Celltrion shares rally in South Korea after EU OKs marketing of its COVID-19 treatment
Celltrion Inc.s shares rallied Monday after the European Commission granted the South Korean biotech firm approval to market its COVID-19 antibody treatment.The European approval of Regdanvimab, marketed by Celltrion as Regkirona in South Korea, drop up…
